Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Patrick Curry, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lipitz-Snyderman A, Vater L, Curry M, Li D, Rubin DM, Radzyner M, Duck E, Bach PB, Schenker Y. Cancer hospital advertising and outcomes: trust the messenger? Lancet Oncol. 2019 Jun; 20(6):760-762. PMID: 31162089.
    Citations:    
  2. Nobel TB, Curry M, Gennarelli R, Jones DR, Molena D. Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients. J Thorac Cardiovasc Surg. 2019 Apr 16. PMID: 31126651.
    Citations:    
  3. de Avila L, Weinstein AA, Estep JM, Curry MP, Golabi P, Escheik C, Birerdinc A, Stepanova M, Gerber L, Younossi ZM. Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. Liver Int. 2019 Apr 08. PMID: 30959554.
    Citations:    
  4. Danford CJ, Iriana S, Shen C, Curry MP, Lai M. Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients. Liver Int. 2019 Jun; 39(6):1165-1173. PMID: 30809932.
    Citations:    
  5. Fridell JA, Niederhaus S, Curry M, Urban R, Fox A, Odorico J. The survival advantage of pancreas after kidney transplant. Am J Transplant. 2019 Mar; 19(3):823-830. PMID: 30188614.
    Citations:    Fields:    
  6. Sarwar A, Chen C, Khwaja K, Malik R, Raven KE, Weinstein JL, Evenson A, Faintuch S, Fisher R, Curry MP, Ahmed M. Primary Stent Placement for Hepatic Artery Stenosis After Liver Transplantation: Improving Primary Patency and Reintervention Rates. Liver Transpl. 2018 10; 24(10):1377-1383. PMID: 30359488.
    Citations:    Fields:    
  7. Manzia TM, Angelico R, Toti L, Angelico C, Quaranta C, Parente A, Blasi F, Iesari S, Sforza D, Baiocchi L, Lerut J, Tisone G. Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation. Liver Transpl. 2018 09; 24(9):1199-1208. PMID: 30129171.
    Citations:    Fields:    
  8. Bourlière M, Gordon SC, Schiff ER, Tran TT, Ravendhran N, Landis CS, Hyland RH, Stamm LM, Zhang J, Dvory-Sobol H, Subramanian GM, Brainard DM, McHutchison JG, Serfaty L, Thompson AJ, Sepe TE, Curry MP, Reddy KR, Manns MP. Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. Lancet Gastroenterol Hepatol. 2018 08; 3(8):559-565. PMID: 29859740.
    Citations:    Fields:    
  9. Babusis D, Curry MP, Kirby B, Park Y, Murakami E, Wang T, Mathias A, Afdhal N, McHutchison JG, Ray AS. Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus. Antimicrob Agents Chemother. 2018 05; 62(5). PMID: 29439971.
    Citations:    Fields:    
  10. Flamm SL, Bacon B, Curry MP, Milligan S, Nwankwo CU, Tsai N, Younossi Z, Afdhal N. Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network. Aliment Pharmacol Ther. 2018 Jun; 47(11):1511-1522. PMID: 29665097.
    Citations: 1     Fields:    
  11. El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A, Charlton M, Manns M, Afdhal NH, Mukamal K, McHutchison J, Brainard DM, Terrault N, Curry MP. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection. Gastroenterology. 2018 06; 154(8):2111-2121.e8. PMID: 29535028.
    Citations: 1     Fields:    Translation:HumansCells
  12. Tucker MA, Elder DE, Curry M, Fraser MC, Pichler V, Zametkin D, Yang XR, Goldstein AM. Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades. J Invest Dermatol. 2018 07; 138(7):1620-1626. PMID: 29408205.
    Citations:    
  13. Ghaziani TT, Liu JJ, Jiang ZG, Nasser I, Khwaja K, Fisher RA, Nahas M, Curry MP. Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient. ACG Case Rep J. 2018; 5:e10. PMID: 29430469.
    Citations:    
  14. Tapper EB, Ezaz G, Patwardhan V, Mellinger J, Bonder A, Curry M, Saini SD. Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage. Liver Int. 2018 03; 38(3):477-483. PMID: 28837249.
    Citations:    Fields:    Translation:Humans
  15. El Sherif O, Afhdal N, Curry M. No one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infection. J Viral Hepat. 2017 10; 24(10):808-813. PMID: 28581634.
    Citations:    Fields:    Translation:HumansCells
  16. Curry MP, Tapper EB, Bacon B, Dieterich D, Flamm SL, Guest L, Kowdley KV, Lee Y, Milligan S, Tsai N, Younossi Z, Afdhal NH. Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients. Aliment Pharmacol Ther. 2017 09; 46(5):540-548. PMID: 28691377.
    Citations: 7     Fields:    Translation:HumansCells
  17. Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R, Ahmed M. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2017 Jul 06. PMID: 28681542.
    Citations:    Fields:    
  18. Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant. 2017 Nov; 17(11):2790-2802. PMID: 28556422.
    Citations: 7     Fields:    Translation:HumansCells
  19. Lim J, Curry MP, Sundaram V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol. 2017 Jun 18; 9(17):771-780. PMID: 28660011.
    Citations:    
  20. Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146. PMID: 28564569.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
  21. Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung JYY, Agarwal K, Lilly L, Strasser SI, Brown KA, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):945-955. PMID: 28437387.
    Citations: 3     Fields:    Translation:Humans
  22. Terrault NA, Berenguer M, Strasser SI, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry MP, Fagiuoli S, Fung JYY, Gane E, Brown KA, Burra P, Charlton M, Pessoa MG, McCaughan GW. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients. Transplantation. 2017 05; 101(5):956-967. PMID: 28437388.
    Citations: 1     Fields:    Translation:Humans
  23. Tapper EB, Afdhal NH, Curry MP. Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C. Transplantation. 2017 05; 101(5):933-937. PMID: 28437385.
    Citations: 4     Fields:    Translation:Humans
  24. Tapper EB, Hughes MS, Buti M, Dufour JF, Flamm S, Firdoos S, Curry MP, Afdhal NH. The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis. Transplantation. 2017 05; 101(5):987-995. PMID: 27495755.
    Citations: 1     Fields:    Translation:Humans
  25. Iriana S, Curry MP, Afdhal NH. Neurologic Manifestations of Hepatitis C Virus Infection. Clin Liver Dis. 2017 08; 21(3):535-542. PMID: 28689591.
    Citations: 2     Fields:    Translation:Humans
  26. Afdhal N, Everson GT, Calleja JL, McCaughan GW, Bosch J, Brainard DM, McHutchison JG, De-Oertel S, An D, Charlton M, Reddy KR, Asselah T, Gane E, Curry MP, Forns X. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension. J Viral Hepat. 2017 10; 24(10):823-831. PMID: 28295923.
    Citations: 3     Fields:    Translation:HumansCells
  27. Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung J, Agarwal K, Lilly L, Strasser SI, Brown K, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES. Transplantation. 2017 Mar 01. PMID: 28252565.
    Citations:    Fields:    
  28. Terrault N, Berenguer M, Strasser S, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry M, Fagiuoli S, Fung JY, Gane E, Brown KA, Burra P, Charlton M, Pessoa M, McCaughan GW. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 2017 Mar 01. PMID: 28252566.
    Citations:    Fields:    
  29. Tapper EB, Beste L, Curry M, Bonder A, Waljee A, Saini S. Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1373-1381.e7. PMID: 28249809.
    Citations:    Fields:    Translation:Humans
  30. Kowdley KV, Sundaram V, Jeon CY, Qureshi K, Latt NL, Sahota A, Lott S, Curry MP, Tsai N, Chaiyakunapruk N, Lee Y, Petersen J, Buggisch P. Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection. Hepatology. 2017 04; 65(4):1094-1103. PMID: 28027579.
    Citations: 15     Fields:    Translation:HumansCells
  31. Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol (NY). 2017 01; 42(1):152-158. PMID: 27472938.
    Citations:    Fields:    Translation:Humans
  32. Medlock M, Weissman A, Wong SS, Carlo A, Zeng M, Borba C, Curry M, Shtasel D. Racism as a Unique Social Determinant of Mental Health: Development of a Didactic Curriculum for Psychiatry Residents. MedEdPORTAL. 2017; 13. PMID: 29387786.
    Citations:    
  33. Shukha K, Mueller JL, Chung RT, Curry MP, Friedman DJ, Pollak MR, Berg AH. Most ApoL1 Is Secreted by the Liver. J Am Soc Nephrol. 2017 Apr; 28(4):1079-1083. PMID: 27932478.
    Citations: 5     Fields:    Translation:Humans
  34. DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension. Pulm Circ. 2016 Dec; 6(4):498-507. PMID: 28090291.
    Citations: 1     
  35. Younossi ZM, Stepanova M, Feld J, Zeuzem S, Sulkowski M, Foster GR, Mangia A, Charlton M, O'Leary JG, Curry MP, Nader F, Henry L, Hunt S. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. Clin Gastroenterol Hepatol. 2017 03; 15(3):421-430.e6. PMID: 27847279.
    Citations: 7     Fields:    Translation:Humans
  36. Smith HL, Chung RT, Mantry P, Chapman W, Curry MP, Schiano TD, Boucher E, Cheslock P, Wang Y, Molrine DC. Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study. J Viral Hepat. 2017 03; 24(3):197-206. PMID: 28127942.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  37. Tapper EB, Bacon BR, Curry MP, Dieterich DT, Flamm SL, Guest LE, Kowdley KV, Lee Y, Tsai NC, Younossi ZM, Afdhal NH. Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study. J Viral Hepat. 2017 01; 24(1):22-27. PMID: 27730717.
    Citations: 8     Fields:    Translation:HumansCells
  38. Tapper EB, Bacon BR, Curry MP, Dieterich DT, Flamm SL, Guest LE, Kowdley KV, Lee Y, Tsai NC, Younossi ZM, Afdhal NH. Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study. Hepatology. 2016 12; 64(6):1893-1899. PMID: 27533287.
    Citations: 9     Fields:    Translation:HumansCells
  39. Younossi ZM, Stepanova M, Charlton M, Curry MP, O'Leary JG, Brown RS, Hunt S. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet Gastroenterol Hepatol. 2016 10; 1(2):122-132. PMID: 28404069.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  40. Lawitz E, Reau N, Hinestrosa F, Rabinovitz M, Schiff E, Sheikh A, Younes Z, Herring R, Reddy KR, Tran T, Bennett M, Nahass R, Yang JC, Lu S, Dvory-Sobol H, Stamm LM, Brainard DM, McHutchison JG, Pearlman B, Shiffman M, Hawkins T, Curry M, Jacobson I. Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial. Gastroenterology. 2016 11; 151(5):893-901.e1. PMID: 27486034.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  41. Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431. PMID: 27415632.
    Citations: 12     Fields:    Translation:Humans
  42. Gambato M, Pérez-Del-Pulgar S, Hedskog C, Svarovskia ES, Brainard D, Denning J, Curry MP, Charlton M, Caro-Pérez N, Londoño MC, Koutsoudakis G, Forns X. Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen. Gastroenterology. 2016 10; 151(4):633-636.e3. PMID: 27373513.
    Citations: 5     Fields:    Translation:HumansCells
  43. Curry MP, Charlton M. Sofosbuvir and Velpatasvir for Patients with HCV Infection. N Engl J Med. 2016 04 28; 374(17):1688. PMID: 27135094.
    Citations:    Fields:    Translation:HumansCells
  44. Patwardhan VR, Jiang ZG, Risech-Neiman Y, Piatkowski G, Afdhal NH, Mukamal K, Curry MP, Tapper EB. Serum Ammonia in Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated Cirrhosis. J Clin Gastroenterol. 2016 Apr; 50(4):345-50. PMID: 26565968.
    Citations: 1     Fields:    Translation:HumansCells
  45. Curry MP. Direct acting antivirals for decompensated cirrhosis. Efficacy and safety are now established. J Hepatol. 2016 06; 64(6):1206-7. PMID: 26948496.
    Citations: 3     Fields:    
  46. Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clin Transplant. 2016 Apr; 30(4):452-60. PMID: 26854475.
    Citations:    Fields:    Translation:HumansCells
  47. Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Charlton M. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med. 2015 Dec 31; 373(27):2618-28. PMID: 26569658.
    Citations: 89     Fields:    Translation:HumansCellsCTClinical Trials
  48. Catana AM, Curry M, Hanto DW. Abdominal Mass Found in a Liver Transplant Recipient. Am J Transplant. 2015 Sep; 15(9):2522-4. PMID: 26288170.
    Citations:    Fields:    Translation:Humans
  49. Hshieh TT, Kaung A, Hussain S, Curry MP, Sundaram V. The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage. Saudi J Gastroenterol. 2015 Jul-Aug; 21(4):254-8. PMID: 26228370.
    Citations: 1     Fields:    Translation:Humans
  50. Patwardhan VR, Curry MP. Reappraisal of the hepatitis C virus-positive donor in solid organ transplantation. Curr Opin Organ Transplant. 2015 Jun; 20(3):267-75. PMID: 25944236.
    Citations: 3     Fields:    Translation:HumansCells
  51. Jain S, Rajasingham R, Noubary F, Coonahan E, Schoeplein R, Baden R, Curry M, Afdhal N, Kumar S, Pollock NR. Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture Samples. PLoS One. 2015; 10(5):e0128118. PMID: 26020244.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  52. DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary Vessel Cross-sectional Area before and after Liver Transplantation: Quantification with Computed Tomography. Acad Radiol. 2015 Jun; 22(6):752-9. PMID: 25770631.
    Citations:    Fields:    Translation:Humans
  53. Tapper EB, Patwardhan VR, Curry M. Low yield and utilization of confirmatory testing in a cohort of patients with liver disease assessed for alpha-1 antitrypsin deficiency. Dig Dis Sci. 2015 Jun; 60(6):1589-94. PMID: 25532504.
    Citations: 3     Fields:    Translation:Humans
  54. Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med. 2014 Nov; 17(11):1271-7. PMID: 25390468.
    Citations: 13     Fields:    Translation:Humans
  55. Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015 Jan; 148(1):108-17. PMID: 25304641.
    Citations: 73     Fields:    Translation:HumansCellsCTClinical Trials
  56. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1. PMID: 25261839.
    Citations: 80     Fields:    Translation:HumansCellsCTClinical Trials
  57. Burke KE, VanderLaan PA, Folch E, Curry MP, McSparron JI. A 50-year-old man with cirrhosis and progressive hypoxemia. Ann Am Thorac Soc. 2014 Sep; 11(7):1149-51. PMID: 25237994.
    Citations:    Fields:    Translation:Humans
  58. Boone MD, Celi LA, Ho BG, Pencina M, Curry MP, Lior Y, Talmor D, Novack V. Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. J Crit Care. 2014 Oct; 29(5):881.e7-13. PMID: 24974049.
    Citations: 6     Fields:    Translation:Humans
  59. Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients. Am J Transplant. 2014 May; 14(5):1129-35. PMID: 24636466.
    Citations: 2     Fields:    Translation:HumansCells
  60. Rodrigue JR, Nelson DR, Hanto DW, Reed AI, Curry MP. Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change. Prog Transplant. 2013 Dec; 23(4):319-28. PMID: 24311395.
    Citations: 5     Fields:    Translation:Humans
  61. Rodrigue JR, Hanto DW, Curry MP. The Alcohol Relapse Risk Assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant. Prog Transplant. 2013 Dec; 23(4):310-8. PMID: 24311394.
    Citations: 8     Fields:    Translation:Humans
  62. Rodrigue JR, Hanto DW, Curry MP. Substance abuse treatment and its association with relapse to alcohol use after liver transplantation. Liver Transpl. 2013 Dec; 19(12):1387-95. PMID: 24123780.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  63. Curry MP. Systematic investigation of elevated transaminases during the third posttransplant month. Liver Transpl. 2013 Nov; 19 Suppl 2:S17-22. PMID: 24019297.
    Citations: 1     Fields:    Translation:Humans
  64. Ujire MP, Curry MP, Stillman IE, Hanto DW, Mandelbrot DA. A simultaneous liver-kidney transplant recipient with IgA nephropathy limited to native kidneys and BK virus nephropathy limited to the transplant kidney. Am J Kidney Dis. 2013 Aug; 62(2):331-4. PMID: 23477799.
    Citations: 1     Fields:    Translation:HumansCells
  65. Curry MP. HIV and hepatitis C virus: special concerns for patients with cirrhosis. J Infect Dis. 2013 Mar; 207 Suppl 1:S40-4. PMID: 23390304.
    Citations: 9     Fields:    Translation:Humans
  66. Bleibel W, Caldwell SH, Curry MP, Northup PG. Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list. Transpl Int. 2013 Apr; 26(4):435-42. PMID: 23356587.
    Citations: 11     Fields:    Translation:Humans
  67. Chung RT, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann JF, Hertl M, Pomposelli JJ, Pomfret EA, Florman S, Schilsky M, Broering TJ, Finberg RW, Szabo G, Zamore PD, Khettry U, Babcock GJ, Ambrosino DM, Leav B, Leney M, Smith HL, Molrine DC. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant. 2013 Apr; 13(4):1047-1054. PMID: 23356386.
    Citations: 35     Fields:    Translation:HumansCells
  68. Hshieh TT, Sundaram V, Najarian RM, Hanto DW, Karp SJ, Curry MP. Hepatitis B surface antigen as a marker for recurrent, metastatic hepatocellular carcinoma after liver transplantation. Liver Transpl. 2012 Aug; 18(8):995-8. PMID: 22829419.
    Citations: 1     Fields:    Translation:Humans
  69. Johnson SR, Karp SJ, Curry MP, Barugel M, Rodrigue JR, Mandelbrot DA, Rogers CP, Hanto DW. Liver transplant center risk tolerance. Clin Transplant. 2012 May-Jun; 26(3):E269-76. PMID: 22686950.
    Citations: 1     Fields:    Translation:Humans
  70. Walker L, Curry M, Nayak A, Lange N, Pierpaoli C. A framework for the analysis of phantom data in multicenter diffusion tensor imaging studies. Hum Brain Mapp. 2013 Oct; 34(10):2439-54. PMID: 22461391.
    Citations: 9     Fields:    Translation:Humans
  71. Francis JM, Palmer MR, Donohoe K, Curry M, Johnson SR, Karp SJ, Evenson AR, Pavlakis M, Hanto DW, Mandelbrot DA. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation. 2012 Mar 15; 93(5):530-5. PMID: 22245875.
    Citations: 6     Fields:    Translation:Humans
  72. Hanto DW, Curry MP, Sun M, Nasser I. Hepatocellular carcinoma (HCC) in a patient with hepatitis B virus (HBV) infection. Am J Transplant. 2012 Mar; 12(3):786-7; quiz 788. PMID: 22372460.
    Citations: 2     Fields:    Translation:HumansCells
  73. Kim M, Curry MP, Rogers CC. Impact of sirolimus duration on hepatitis C related fibrosis progression in liver transplant recipients. Am J Transplant. 2012 May; 12(5):1356-7. PMID: 22299778.
    Citations: 1     Fields:    Translation:Humans
  74. Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012 May; 142(5):1132-1139.e1. PMID: 22285805.
    Citations: 19     Fields:    Translation:Humans
  75. Rodrigue JR, Hanto DW, Curry MP. Patients' expectations and success criteria for liver transplantation. Liver Transpl. 2011 Nov; 17(11):1309-17. PMID: 21656656.
    Citations: 2     Fields:    Translation:Humans
  76. Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry MP. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation? Prog Transplant. 2011 Sep; 21(3):207-14. PMID: 21977881.
    Citations: 4     Fields:    Translation:Humans
  77. Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal NH. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012 Feb; 19(2):e184-93. PMID: 22239518.
    Citations: 22     Fields:    Translation:Humans
  78. Rodrigue JR, Hanto DW, Curry MP. Patients' willingness to accept expanded criteria donor liver transplantation. Am J Transplant. 2011 Aug; 11(8):1705-11. PMID: 21672150.
    Citations: 2     Fields:    Translation:Humans
  79. Karp SJ, Johnson S, Evenson A, Curry MP, Manning D, Malik R, Lake-Bakaar G, Lai M, Hanto D. Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford). 2011 Jun; 13(6):411-6. PMID: 21609374.
    Citations: 7     Fields:    Translation:Humans
  80. Rodrigue JR, Dimitri N, Reed A, Antonellis T, Hanto DW, Curry M. Quality of life and psychosocial functioning of spouse/partner caregivers before and after liver transplantation. Clin Transplant. 2011 Mar-Apr; 25(2):239-47. PMID: 20184628.
    Citations: 5     Fields:    Translation:Humans
  81. Pritchett S, Cardenas A, Manning D, Curry M, Afdhal NH. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat. 2011 Apr; 18(4):e75-80. PMID: 21040236.
    Citations: 17     Fields:    Translation:Humans
  82. Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry M. Fatigue and sleep quality before and after liver transplantation. Prog Transplant. 2010 Sep; 20(3):221-33. PMID: 20929106.
    Citations: 3     Fields:    Translation:Humans
  83. Afdhal NH, Curry MP. Early TIPS to improve survival in acute variceal bleeding. N Engl J Med. 2010 Jun 24; 362(25):2421-2. PMID: 20573931.
    Citations: 6     Fields:    Translation:Humans
  84. Coffin CS, Stock PG, Dove LM, Berg CL, Nissen NN, Curry MP, Ragni M, Regenstein FG, Sherman KE, Roland ME, Terrault NA. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant. 2010 May; 10(5):1268-75. PMID: 20346065.
    Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
  85. Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Florman S, Blumberg E, Stosor V, Jayaweera DT, Huprikar S, Fung J, Pruett T, Stock P, Ragni M. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64. PMID: 19800334.
    Citations: 19     Fields:    Translation:Humans
  86. Rogers CC, Johnson SR, Mandelbrot DA, Pavlakis M, Horwedel T, Karp SJ, Egbuna O, Rodrigue JR, Chudzinski RE, Goldfarb-Rumyantzev AS, Hanto DW, Curry MP. Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients. Clin Transplant. 2009 Nov-Dec; 23(6):887-96. PMID: 19681971.
    Citations: 6     Fields:    Translation:Humans
  87. Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2009 Apr; 24(4):564-8. PMID: 19378390.
    Citations: 23     Fields:    Translation:Humans
  88. Ho KJ, Owens CD, Johnson SR, Khwaja K, Curry MP, Pavlakis M, Mandelbrot D, Pomposelli JJ, Shah SA, Saidi RF, Ko DS, Malek S, Belcher J, Hull D, Tullius SG, Freeman RB, Pomfret EA, Whiting JF, Hanto DW, Karp SJ. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation. 2008 Jun 15; 85(11):1588-94. PMID: 18551064.
    Citations: 10     Fields:    Translation:Humans
  89. Wissam Bleibel Michael Curry Sanjiv Chopra. Nodular Regenerative Hyperplasia. 2008.
  90. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007 Dec; 47(6):760-7. PMID: 17928090.
    Citations: 69     Fields:    Translation:Humans
  91. Cárdenas A, Curry M, Afdhal NH. The not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites. Dig Dis Sci. 2007 Apr; 52(4):939-40. PMID: 17308970.
    Citations:    Fields:    Translation:Humans
  92. Johnson SR, Alexopoulos S, Curry M, Hanto DW. Primary nonfunction (PNF) in the MELD Era: An SRTR database analysis. Am J Transplant. 2007 Apr; 7(4):1003-9. PMID: 17286618.
    Citations: 8     Fields:    Translation:Humans
  93. Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol. 2007 Apr; 46(4):543-5. PMID: 17316879.
    Citations: 6     Fields:    Translation:Humans
  94. Curry MP, Afdhal NH. Prophylaxis Against Recurrent HBV Infection after Liver Transplantation. Current Hepatitis Reports. 2007; 6.
  95. Karp SJ, Ku Y, Johnson S, Khwaja K, Curry M, Hanto, D. Surgical and Non-surgical Treatment for Hepatocellular Cancer. Current Opinion in Transplantation. 2006; 11(3):226-233.
  96. Johnson SR, Pavlakis M, Khwaja K, Karp SJ, Curry M, Curran CC, Monaco AP, Hanto DW. Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death. Transplantation. 2005 Nov 15; 80(9):1244-50. PMID: 16314792.
    Citations: 1     Fields:    Translation:Humans
  97. Curry MP, Afdhal NH. Use of growth factors with antiviral therapy for chronic hepatitis C. Clin Liver Dis. 2005 Aug; 9(3):439-51, vii. PMID: 16023976.
    Citations: 3     Fields:    Translation:Humans
  98. Curry MP, Hegarty JE. The gallbladder and biliary tract in cystic fibrosis. Curr Gastroenterol Rep. 2005 May; 7(2):147-53. PMID: 15802104.
    Citations: 2     Fields:    Translation:Humans
  99. Lima MA, Hanto DW, Curry MP, Wong MT, Dang X, Koralnik IJ. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol. 2005 Feb; 11(1):46-50. PMID: 15804958.
    Citations: 3     Fields:    Translation:HumansCells
  100. Curry MP Chopra S. Hepatic Vascular Disorders. Hepatology: a practical approach. Al Knawy B, Shiffman M, Weisner R editors. 2005.
  101. Curry MP. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation. 2004 Oct 15; 78(7):955-63. PMID: 15480158.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  102. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E, Kelleher D. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology. 2004 Jul; 40(1):108-14. PMID: 15239092.
    Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
  103. Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology. 2004 Jul; 40(1):125-32. PMID: 15239095.
    Citations: 24     Fields:    Translation:HumansCells
  104. Curry MP Chopra S. Acute Viral Hepatitis. Mandell, Douglas and Bennett’s principles an practice of Infectious Disease. Mandell, Bennett, Dolin editors. 2004.
  105. Curry MP. New Developements in the treatment of Hepatitis C. Forum: Journal of the Irish College of General Practitioners. 2004; 21(1):35-36.
  106. Curry MP, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M, Nolan N, Hall W, Hegarty JE, O'Farrelly C. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol. 2003 May; 38(5):642-50. PMID: 12713876.
    Citations: 16     Fields:    Translation:HumansCells
  107. Norris S, Doherty DG, Curry M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother. 2003 Jan; 52(1):53-8. PMID: 12536240.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  108. Duffy M, Salemi M, Sheehy N, Vandamme AM, Hegarty J, Curry M, Nolan N, Kelleher D, McKiernan S, Hall WW. Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection. Virology. 2002 Sep 30; 301(2):354-64. PMID: 12359437.
    Citations: 7     Fields:    Translation:HumansCells
  109. Deignan T, Curry MP, Doherty DG, Golden-Mason L, Volkov Y, Norris S, Nolan N, Traynor O, McEntee G, Hegarty JE, O'Farrelly C. Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol. 2002 Jul; 37(1):101-8. PMID: 12076868.
    Citations: 33     Fields:    Translation:HumansCells
  110. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J, Curry M, Mills KH. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis. 2002 Mar 15; 185(6):720-7. PMID: 11920289.
    Citations: 59     Fields:    Translation:HumansCells
  111. Curry MP Chopra S. Hepatic Hemangioma. Rose BD (Editor). 2002.
  112. Curry MP Afdhal, NH. Hepatic Adenoma. Rose BD (Editor). 2002.
  113. Maguire OC, Curry MP, O'Gorman P, Parfrey N, Hegarty J, Cunningham SK. In vitro cold activation of complement shown by an overestimation of total complement 4: a study in patients with hepatitis C virus infection. Ann Clin Biochem. 2001 Nov; 38(Pt 6):687-93. PMID: 11732652.
    Citations:    Fields:    Translation:Humans
  114. Curry MP, Newlon JL, Watson DW. Cavernous sinus metastasis from laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2001 Nov; 125(5):567-8. PMID: 11700465.
    Citations: 3     Fields:    Translation:Humans
  115. Curry MP, Koziel M. Immunobiology of Hepatitis Viruses. Hepatitis Viruses. Ou JHJ. 2001; 171-212.
  116. Curry MP, Koziel M. The dynamics of the immune response in acute hepatitis B: new lessons using new techniques. Hepatology. 2000 Nov; 32(5):1177-9. PMID: 11050074.
    Citations: 3     Fields:    Translation:Humans
  117. Golden Mason L, Kelly A, Curry MP, Kelly J, Traynor O, McEntee G, Hegarty JE, O’Farrelly C. . Interleukin-7 mRNA and protein levels in the normal adult liver: implications for hepatic T-cell differentiation. Hepatology. 2000; 32(4):202A.
  118. Curry MP, Norris S, Golden-Mason L, Doherty DG, Deignan T, Collins C, Traynor O, McEntee GP, Hegarty JE, O'Farrelly C. Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization. J Immunol Methods. 2000 Aug 28; 242(1-2):21-31. PMID: 10986386.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  119. Maceneaney PM, Malone DE, Skehan SJ, Curry MP, Miller JC, Gibney RG, Traynor O, Mccormick PA. The role of hepatic arterial Doppler ultrasound after liver transplantation: an 'audit cycle' evaluation. Clin Radiol. 2000 Jul; 55(7):517-24. PMID: 10924374.
    Citations: 4     Fields:    Translation:Humans
  120. McKiernan SM, Hagan R, Curry M, McDonald GS, Nolan N, Crowley J, Hegarty J, Lawlor E, Kelleher D. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology. 2000 Jun; 118(6):1124-30. PMID: 10833487.
    Citations: 15     Fields:    Translation:Humans
  121. Golden-Mason L, Curry MP, Nolan N, Traynor O, McEntee G, Kelly J, Hegarty JE, O'Farrelly C. Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver. Hepatology. 2000 Jun; 31(6):1251-6. PMID: 10827150.
    Citations: 7     Fields:    Translation:HumansCells
  122. Curry MP, Golden-Mason L, Nolan N, Parfrey NA, Hegarty JE, O'Farrelly C. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection. J Hepatol. 2000 Jan; 32(1):121-5. PMID: 10673076.
    Citations: 9     Fields:    Translation:HumansCells
  123. Curry MP, Hegarty JE. Gallbladder and Biliary Tree in Cystic Fibrosis. Diseases of the gall bladder and biliary tract. Afdhal. 2000; 387-406.
  124. Curry MP Afdhal NH. Non-invasive markers of hepatic fibrosis. Rose BD (Editor). 2000.
  125. Crosbie OM, Freaney R, McKenna MJ, Curry MP, Hegarty JE. Predicting bone loss following orthotopic liver transplantation. Gut. 1999 Mar; 44(3):430-4. PMID: 10026333.
    Citations: 5     Fields:    Translation:Humans
  126. McCormick PA, Kennedy F, Curry M, Traynor O. COX 2 inhibitor and fulminant hepatic failure. Lancet. 1999 Jan 02; 353(9146):40-1. PMID: 10023957.
    Citations: 13     Fields:    Translation:Humans
  127. Golden-Mason L, Curry MP, Traynor O, McEntee G, Kelly J, Hegarty JE, O’Farrelly C. Hepatic haemopoietic stem cells in end-stage alcoholic liver disease. Hepatology. 1998.
  128. Neelamekam TK, Geoghegan JG, Curry M, Hegarty JE, Traynor O, McEntee GP. Delayed correction of portal hypertension after portal vein conduit arterialization in liver transplantation. Transplantation. 1997 Apr 15; 63(7):1029-30. PMID: 9112360.
    Citations: 2     Fields:    Translation:Humans
  129. Curry MP, Kaminski G, Dooley S, Traynor O, McEntee G, McCormick A, Nolan N, Parfrey NA, Hegarty JE. Hepatitis G Virus infection following Liver Transplantation. Irish Journal of Medical Science. 1996.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Curry's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (434)
Explore
_
Co-Authors (72)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.